(2024-2033) Wearable Medical Devices Market Size, Share, Trends, Industry Growth Analysis and Forecast | AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation

Overview and Scope

Women’s health is the area of medicine that focuses on the identification and management of ailments and illnesses that have an impact on a woman’s physical and psychological health.

Sizing and Forecast

The women’s health market size has grown steadily in recent years. It will grow from $41.22 billion in 2023 to $43.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to advancements in reproductive medicine, awareness and education initiatives, empowerment and advocacy movements, prenatal and postnatal care advances, development of hormone replacement therapies..

The women’s health market size is expected to see strong growth in the next few years. It will grow to $53.69 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to precision medicine in gynecology, rise in female-focused clinical trials, expanded use of non-invasive prenatal testing, expanded access to fertility treatments, increasing focus on mental health.. Major trends in the forecast period include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women’s health diagnostics, integration of artificial intelligence (ai)..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

The women’s health market covered in this report is segmented –

1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline
2) By Age: 50 Years & above , Other Ages
3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries
4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

North America was the largest region in the women’s health market in 2023. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=8017&type=smp

Major Driver Impacting Market Growth

The rising prevalence of women-centric diseases is expected to propel the growth of the women’s health market going forward. The women-centric diseases such as anemia, osteoporosis, breast cancer, menopause, and others are highly occurring due to various risk factors such as family history, increasing age, early onset of periods or menopause after 55 years, obesity, and others. This rising prevalence of women-centric diseases drives demand for women’s health products and services that are required to treat these diseases and ensure the health and wellness of women. For instance, American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer published an article in January 2023, according to which, cervical cancer was once one of the most common causes of cancer death for American women. About 13,960 new cases of invasive cervical cancer will be diagnosed in the USA in 2023 and from that around 4,310 women is expected to die from cervical cancer. Therefore, the rising prevalence of women-centric diseases is driving the growth of the women’s health market.

Key Industry Players

Major companies operating in the women’s health market report are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Amgen Inc., Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Allergan Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Siemens AG, Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Oviva Therapeutics Inc., Samphire Neuro Inc., Scailyte AG, Syrona Health AG

The women’s health market report table of contents includes:

1. Executive Summary

2. Women’s Health Characteristics

3. Women’s Health Trends And Strategies

4. Women’s Health – Macro Economic Scenario

5. Global Women’s Health Size and Growth

…..

32. Global Women’s Health Competitive Benchmarking

33. Global Women’s Health Competitive Dashboard

34. Key Mergers And Acquisitions In The Women’s Health

35. Women’s Health Future Outlook and Potential Analysis

36. Appendix